Evidence map›Paper›PMID 35479276›Full record

ArticleFrontiers in cardiovascular medicine2022

Aberrant Expression of Cardiac Troponin-T in Lung Cancer Tissues in Association With Pathological Severity.

Toshihiro Tsuruda, Yuichiro Sato, Masaki Tomita, Hiroyuki Tanaka, Kinta Hatakeyama, Misa Otsu, Aya Kawano, Keiko Nagatomo, Naoki Yoshikawa, Ryuji Ikeda and 2 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cardiovascular medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Toshihiro TsurudaDivision of Cardiovascular Medicine and Nephrology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.
Yuichiro SatoDepartment of Diagnostic Pathology, Faculty of Medicine, Miyazaki University Hospital, Miyazaki, Japan.
Masaki TomitaDepartment of Thoracic and Breast Surgery, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.
Hiroyuki TanakaDepartment of Pathology, Section of Oncopathology and Regenerative Biology, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.
Kinta HatakeyamaDepartment of Pathology, National Cerebral and Cardiovascular Center, Osaka, Japan.
Misa OtsuDivision of Cardiovascular Medicine and Nephrology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.
Aya KawanoDivision of Cardiovascular Medicine and Nephrology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.
Keiko NagatomoDivision of Cardiovascular Medicine and Nephrology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.
Naoki YoshikawaDepartment of Pharmacy, Faculty of Medicine, Miyazaki University Hospital, Miyazaki, Japan.
Ryuji IkedaDepartment of Pharmacy, Faculty of Medicine, Miyazaki University Hospital, Miyazaki, Japan.
Yujiro AsadaDepartment of Pathology, Faculty of Medicine, Miyazaki University Hospital, Miyazaki, Japan.
Koichi KaikitaDivision of Cardiovascular Medicine and Nephrology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.
University of Miyazaki · JPUniversity of Miyazaki Hospital · JPNational Cerebral and Cardiovascular Center · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Cardiac troponin-T ( Methods and Results: We used paraffin-embedded blocks of 68 patients with lung cancer (age, 68 ± 11 years old; early-stage, 33; advance-stage, 35) at Miyazaki University Hospital, Japan between January 1, 2017, and March 31, 2019. We stained the slide sections with primary monoclonal antibody against Conclusions: Our data suggest the aberrant expression of

Indexed as

immune checkpoint inhibitorlung cancermyocarditispathologytroponin

Identifiers

PMID35479276
PMCPMC9037982
OpenAlexW4223508719

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.